Swiss-based pharmaceuticals giant Novartis said Monday it was acquiring Selexys Pharmaceuticals Corp., a US research lab in blood and inflammatory disorders, in a deal costing up to $665 million (627 million euros).
Selexys specialises in sickle cell disease, an inherited form of anaemia that is most common among people of African descent.
GMT 12:07 2018 Tuesday ,23 January
Syria Kurds urge civilians to take up arms against Turk assaultGMT 12:03 2018 Tuesday ,23 January
Egypt military accuses presidential hopeful of crimes including forgeryGMT 11:41 2018 Tuesday ,23 January
UK regulator says Fox's Sky takeover 'not in public interest'GMT 11:38 2018 Tuesday ,23 January
South African jazz legend Hugh Masekela diesGMT 11:36 2018 Tuesday ,23 January
EU removes eight countries from tax haven listGMT 11:32 2018 Tuesday ,23 January
8.2 magnitude quake hits off Alaska: USGSGMT 11:28 2018 Tuesday ,23 January
Mattis calls for Turkish 'restraint' in SyriaGMT 03:43 2018 Tuesday ,23 January
Turkish soldier killed in Syria operation: armyMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor